<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35449732</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.</ArticleTitle><Pagination><StartPage>861703</StartPage><MedlinePgn>861703</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">861703</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2022.861703</ELocationID><Abstract><AbstractText>Many discharged COVID-19 patients affected by sequelae experience reduced quality of life leading to an increased burden on the healthcare system, their families and society at large. Possible pathophysiological mechanisms of long COVID include: persistent viral replication, chronic hypoxia and inflammation. Ongoing vascular endothelial damage promotes platelet adhesion and coagulation, resulting in the impairment of various organ functions. Meanwhile, thrombosis will further aggravate vasculitis contributing to further deterioration. Thus, long COVID is essentially a thrombotic sequela. Unfortunately, there is currently no effective treatment for long COVID. This article summarizes the evidence for coagulation abnormalities in long COVID, with a focus on the pathophysiological mechanisms of thrombosis. Extracellular vesicles (EVs) released by various types of cells can carry SARS-CoV-2 through the circulation and attack distant tissues and organs. Furthermore, EVs express tissue factor and phosphatidylserine (PS) which aggravate thrombosis. Given the persistence of the virus, chronic inflammation and endothelial damage are inevitable. Pulmonary structural changes such as hypertension, embolism and fibrosis are common in long COVID. The resulting impaired lung function and chronic hypoxia again aggravates vascular inflammation and coagulation abnormalities. In this article, we also summarize recent research on antithrombotic therapy in COVID-19. There is increasing evidence that early anticoagulation can be effective in improving outcomes. In fact, persistent systemic vascular inflammation and dysfunction caused by thrombosis are key factors driving various complications of long COVID. Early prophylactic anticoagulation can prevent the release of or remove procoagulant substances, thereby protecting the vascular endothelium from damage, reducing thrombotic sequelae, and improving quality of life for long-COVID patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wang, Yu, Jing, Wu, Novakovic, Xie and Shi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chengyue</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Haijiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Valerie A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Research, Veterans Affairs (VA) Boston Healthcare System, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Rujuan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jialan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital of Harbin, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, Veterans Affairs (VA) Boston Healthcare System, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic hypoxia</Keyword><Keyword MajorTopicYN="N">early anticoagulation</Keyword><Keyword MajorTopicYN="N">endothelial injury</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">phosphatidylserine</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35449732</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M., Mentzer S. J., Kolb M., Jonigk D. (2020. a). Inflammation and Intussusceptive Angiogenesis in COVID-19: Everything in and Out of Flow. Eur. Respir. J. 56, 2003147. doi:&#xa0;10.1183/13993003.03147-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03147-2020</ArticleId><ArticleId IdType="pmc">PMC7530910</ArticleId><ArticleId IdType="pubmed">33008942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. . (2020. b). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 383, 120&#x2013;128. doi:&#xa0;10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad M. S., Shaik R. A., Ahmad R. K., Yusuf M., Khan M., Almutairi A. B., et al. . (2021). &#x201c;Long Covid&#x201d;: An Insight. Eur. Rev. Med. Pharmacol. Sci. 25, 5561&#x2013;5577. doi:&#xa0;10.26355/eurrev_202109_26669</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202109_26669</ArticleId><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O. L., Hughes S. E., Turner G., Rivera S. C., McMullan C., Chandan J. S., et al. . (2021). Symptoms, Complications and Management of Long COVID: A Review. J. R. Soc Med. 114, 428&#x2013;442. doi:&#xa0;10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M. S., Omrani O. A., Fawzy N. A., Shaar B. A., Almamlouk R., Riaz M., et al. . (2022). Prevalence of Post-Acute COVID-19 Syndrome Symptoms at Different Follow-Up Periods: A Systematic Review and Meta-Analysis. Clin. Microbiol. Infect. S1198-743X (22). doi:&#xa0;10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Althaus K., Marini I., Zlamal J., Pelzl L., Singh A., H&#xe4;berle H., et al. . (2021). Antibody-Induced Procoagulant Platelets in Severe COVID-19 Infection. Blood 137, 1061&#x2013;1071. doi:&#xa0;10.1182/blood.2020008762</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008762</ArticleId><ArticleId IdType="pmc">PMC7791311</ArticleId><ArticleId IdType="pubmed">33512415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I., Molino A., Moretta P., Lupoli R., Spedicato G. A., et al. . (2021). Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 9, 957. doi:&#xa0;10.3390/biomedicines9080957</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080957</ArticleId><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E. M., Spallone A., Rodriguez-Barradas M. C., Sahly H. M., Atmar R. L., Kulkarni P. A. (2020). Postacute COVID-19: An Overview and Approach to Classification. Open Forum. Infect. Dis. 7, ofaa509. doi:&#xa0;10.1093/ofid/ofaa509</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Arga&#xf1;araz G. A., Palmeira J. D. F., Arga&#xf1;araz E. R. (2020). Phosphatidylserine Inside Out: A Possible Underlying Mechanism in the Inflammation and Coagulation Abnormalities of COVID-19. Cell Commun. Signal. 18, 190. doi:&#xa0;10.1186/s12964-020-00687-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-020-00687-7</ArticleId><ArticleId IdType="pmc">PMC7765775</ArticleId><ArticleId IdType="pubmed">33357215</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan Y., Yilmaz G., Dogan D., Hasirci M., Cetindogan H., Ocal N., et al. . (2021). The Effectiveness of Early Anticoagulant Treatment in COVID-19 Patients. Phlebology 36, 384&#x2013;391. doi:&#xa0;10.1177/0268355520975595</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0268355520975595</ArticleId><ArticleId IdType="pubmed">33243082</ArticleId></ArticleIdList></Reference><Reference><Citation>Atallah B., Sadik Z. G., Salem N., El, Nekidy W. S., Almahmeed W., Park W. M., et al. . (2021). The Impact of Protocol-Based High-Intensity Pharmacological Thromboprophylaxis on Thrombotic Events in Critically Ill COVID-19 Patients. Anaesthesia 76, 327&#x2013;335. doi:&#xa0;10.1111/anae.15300</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15300</ArticleId><ArticleId IdType="pmc">PMC7675553</ArticleId><ArticleId IdType="pubmed">33047335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahloul M., Ketata W., Lahyeni D., Mayoufi H., Kotti A., Smaoui F., et al. . (2021). Pulmonary Capillary Leak Syndrome Following COVID-19 Virus Infection. J.&#xa0;Med. Virol. 93, 94&#x2013;96. doi:&#xa0;10.1002/jmv.26152</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26152</ArticleId><ArticleId IdType="pmc">PMC7300440</ArticleId><ArticleId IdType="pubmed">32519786</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Vanella V. V., Falasca M., Caneapero V., Cappellano G., Raineri D., et al. . (2021). Circulating Exosomes are Strongly Involved in SARS-Cov-2 Infection. Front. Mol. Biosci. 8. doi:&#xa0;10.3389/fmolb.2021.632290</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.632290</ArticleId><ArticleId IdType="pmc">PMC7937875</ArticleId><ArticleId IdType="pubmed">33693030</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes G. D., Burnett A., Allen A., Blumenstein M., Clark N. P., Cuker A., et al. . (2020). Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic: Interim Clinical Guidance From the Anticoagulation Forum. J.&#xa0;Thromb. Thrombolysis. 50, 72&#x2013;81. doi:&#xa0;10.1007/s11239-020-02138-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02138-z</ArticleId><ArticleId IdType="pmc">PMC7241581</ArticleId><ArticleId IdType="pubmed">32440883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevers E. M., Williamson P. L. (2016). Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. Physiol. Rev. 96, 605&#x2013;645. doi:&#xa0;10.1152/physrev.00020.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00020.2015</ArticleId><ArticleId IdType="pubmed">26936867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Madhavan M. V., Jimenez D., Chuich T., Dreyfus I., Driggin E., et al. . (2020). COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 75, 2950&#x2013;2973. doi:&#xa0;10.1016/j.jacc.2020.04.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnhuber A., Flie&#xdf;er E., Gorkiewicz G., Zacharias M., Seeliger B., David S., et al. . (2021). Between Inflammation and Thrombosis: Endothelial Cells in COVID-19. Eur. Respir. J. 58, 2100377. doi:&#xa0;10.1183/13993003.00377-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00377-2021</ArticleId><ArticleId IdType="pmc">PMC8112008</ArticleId><ArticleId IdType="pubmed">33958433</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowiec B. M., Angelova, Volponi A., Mozdziak P., Kempisty B., Dyszkiewicz-Konwi&#x144;ska M. (2021). Small Extracellular Vesicles and COVID19-Using the &#x201c;Trojan Horse&#x201d; to Tackle the Giant. Cells 10, 3383. doi:&#xa0;10.3390/cells10123383</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123383</ArticleId><ArticleId IdType="pmc">PMC8699232</ArticleId><ArticleId IdType="pubmed">34943891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradbury C. A., McQuilten Z. (2022). Anticoagulation in COVID-19. Lancet 399, 5&#x2013;7. doi:&#xa0;10.1016/S0140-6736(21)02503-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02503-4</ArticleId><ArticleId IdType="pmc">PMC8673870</ArticleId><ArticleId IdType="pubmed">34921757</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerai Martimbianco A. L., Pacheco R. L., Bagattini &#xc2;.M., Riera R. (2021). Frequency, Signs and Symptoms, and Criteria Adopted for Long COVID-19: A Systematic Review. Int. J. Clin. Pract. 75, e14357. doi:&#xa0;10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappellano G., Raineri D., Rolla R., Giordano M., Puricelli C., Vilardo B., et al. . (2021). Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of SARS-CoV-2 Infection. Cells 10, 85. doi:&#xa0;10.3390/cells10010085</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010085</ArticleId><ArticleId IdType="pmc">PMC7825711</ArticleId><ArticleId IdType="pubmed">33430260</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA 324, 603&#x2013;605. doi:&#xa0;10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D., Guido G., Zerunian M., Polidori T., Lucertini E., Pucciarelli F., et al. . (2021). Post-Acute Sequelae of COVID-19 Pneumonia: Six-Month Chest CT Follow-Up. Radiology 301, E396&#x2013;E405. doi:&#xa0;10.1148/radiol.2021210834</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210834</ArticleId><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L. M. W., Lee Y., Gill H., Teopiz K. M., et al. . (2021). Fatigue and Cognitive Impairment in Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. Brain. Behav. Immun. 101, 93&#x2013;135. doi:&#xa0;10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., et al. . (2021). Long COVID-19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCoV Study. Front. Cardiovasc. Med. 8. doi:&#xa0;10.3389/fcvm.2021.745758. Ibn, Hadj.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Amelia A., Ashdown G. W., Mueller I., Coussens A. K., Eriksson E. M. (2021). Risk Surveillance and Mitigation: Autoantibodies as Triggers and Inhibitors of Severe Reactions to SARS-CoV-2 Infection. Mol. Med. 27, 160. doi:&#xa0;10.1186/s10020-021-00422-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00422-z</ArticleId><ArticleId IdType="pmc">PMC8686808</ArticleId><ArticleId IdType="pubmed">34930107</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung P. C., Eisch A. R., Maleque N., Polly D. M., Auld S. C., Druey K. M. (2021). Fatal Exacerbations of Systemic Capillary Leak Syndrome Complicating Coronavirus Disease. Emerg. Infect. Dis. 27, 2529&#x2013;2534. doi:&#xa0;10.3201/eid2710.211155</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2710.211155</ArticleId><ArticleId IdType="pmc">PMC8462330</ArticleId><ArticleId IdType="pubmed">34314669</ArticleId></ArticleIdList></Reference><Reference><Citation>Congiu T., Demontis R., Cau F., Piras M., Fanni D., Gerosa C., et al. . (2021). Scanning Electron Microscopy of Lung Disease Due to COVID-19 - A Case Report and a Review of the Literature. Eur. Rev. Med. Pharmacol. Sci. 25, 7997&#x2013;8003. doi:&#xa0;10.26355/eurrev_202112_27650</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27650</ArticleId><ArticleId IdType="pubmed">34982463</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. (2021). Long Covid-Mechanisms, Risk Factors, and Management. BMJ 374, n1944. doi:&#xa0;10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G., Porres-Aguilar M., Puebla-Aldama D., Barrag&#xe1;n-Mart&#xed;nez M. D. P., Jurado-Hern&#xe1;ndez M. Y., Garc&#xed;a-C&#xe9;sar M., et al. . (2022). Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia. Curr. Probl. Cardiol. 47, 101004. doi:&#xa0;10.1016/j.cpcardiol.2021.101004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2021.101004</ArticleId><ArticleId IdType="pmc">PMC8482545</ArticleId><ArticleId IdType="pubmed">34601005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A., Tseng E. K., Nieuwlaat R., Angchaisuksiri P., Blair C., Dane K., et al. . (2022). American Society of Hematology Living Guidelines on the Use of Anticoagulation for Thromboprophylaxis in Patients With COVID-19: July 2021 Update on Postdischarge Thromboprophylaxis. Blood Adv. 6, 664&#x2013;671. doi:&#xa0;10.1182/bloodadvances.2021005945</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005945</ArticleId><ArticleId IdType="pmc">PMC8566097</ArticleId><ArticleId IdType="pubmed">34727173</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng F., Wang S., Xu R., Yu W., Wang X., Zhang L. (2018). Endothelial Microvesicles in Hypoxic Hypoxia Diseases. J. Cell. Mol. Med. 22, 3708&#x2013;3718. doi:&#xa0;10.1111/jcmm.13671</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13671</ArticleId><ArticleId IdType="pmc">PMC6050493</ArticleId><ArticleId IdType="pubmed">29808945</ArticleId></ArticleIdList></Reference><Reference><Citation>Desimmie B. A., Raru Y. Y., Awadh H. M., He P., Teka S., Willenburg K. S. (2021). Insights Into SARS-CoV-2 Persistence and Its Relevance. Viruses 13, 1025. doi:&#xa0;10.3390/v13061025</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061025</ArticleId><ArticleId IdType="pmc">PMC8228265</ArticleId><ArticleId IdType="pubmed">34072390</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelen M. M., Vandenbriele C., Balthazar T., Claeys E., Gunst J., Guler I., et al. . (2021). Venous Thromboembolism in Patients Discharged After COVID-19 Hospitalization. Semin. Thromb. Hemost. 47, 362&#x2013;371. doi:&#xa0;10.1055/s-0041-1727284</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1727284</ArticleId><ArticleId IdType="pubmed">33893631</ArticleId></ArticleIdList></Reference><Reference><Citation>Eswaran H., Jarmul J. A., Shaheen A. W., Meaux D., Long T., Saccoccio D., et al. . (2021). Vascular Thromboembolic Events Following COVID-19 Hospital Discharge: Incidence and Risk Factors. Res. Pract. Thromb. Haemost. 5, 292&#x2013;295. doi:&#xa0;10.1002/rth2.12485</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12485</ArticleId><ArticleId IdType="pmc">PMC7938613</ArticleId><ArticleId IdType="pubmed">33733027</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C. E. (2019). Hypoxia and HIF Activation as a Possible Link Between Sepsis and Thrombosis. Thromb. J. 17, 16. doi:&#xa0;10.1186/s12959-019-0205-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-019-0205-9</ArticleId><ArticleId IdType="pmc">PMC6693167</ArticleId><ArticleId IdType="pubmed">31423111</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymieux S., Uzbekov R., Rouill&#xe9; Y., Blanchard E., Hourioux C., Dubuisson J., et al. . (2021). Secretory Vesicles Are the Principal Means of SARS-Cov-2 Egress. Cells 10, 2047. doi:&#xa0;10.3390/cells10082047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082047</ArticleId><ArticleId IdType="pmc">PMC8393858</ArticleId><ArticleId IdType="pubmed">34440816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., S&#xe1;nchez-Serrano N., Mielgo-Ayuso J., Garc&#xed;a-Hern&#xe1;ndez J. L., Gonz&#xe1;lez-Bernal J. J., Seco-Calvo J. (2021). Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? J. Clin. Med. 10, 5799. doi:&#xa0;10.3390/jcm10245799</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245799</ArticleId><ArticleId IdType="pmc">PMC8708091</ArticleId><ArticleId IdType="pubmed">34945095</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R., Enjyoji K., Schmaier A. A. (2022). Vasculopathy in COVID-19. Blood, blood.2021012250. doi:&#xa0;10.1182/blood.2021012250</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., et al. . (2021). Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome. J. Thromb. Haemost. 19, 2546&#x2013;2553. doi:&#xa0;10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J., Padilla S., Fern&#xe1;ndez-Gonz&#xe1;lez M., Garc&#xed;a J. A., Agull&#xf3; V., Andreo M., et al. . (2021). Antibody Response to SARS-CoV-2 Is Associated With Long-Term Clinical Outcome in Patients With COVID-19: A Longitudinal Study. J. Clin. Immunol. 41, 1490&#x2013;1501. doi:&#xa0;10.1007/s10875-021-01083-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D., Allen S. L., Tsang J., Flint S., Pinhasov T., Williams S., et al. . (2020). Postdischarge Thromboembolic Outcomes and Mortality of Hospitalized Patients With COVID-19: The CORE-19 Registry. Blood 137, 2838&#x2013;2847. doi:&#xa0;10.1182/blood.2020010529</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020010529</ArticleId><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Ochoa A. J., Raffetto J. D., Hern&#xe1;ndez A. G., Zavala N., Guti&#xe9;rrez O., Vargas A., et al. . (2021). Sulodexide in the Treatment of Patients With Early Stages of COVID-19: A Randomized Controlled Trial. Thromb. Haemost. 121, 944&#x2013;954. doi:&#xa0;10.1055/a-1414-5216</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1414-5216</ArticleId><ArticleId IdType="pubmed">33677827</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A. E., Ba D. M., Parsons N., Poudel G. R., et al. . (2021). Short-Term and Long-Term Rates of Postacute Sequelae of SARS-Cov-2 Infection: A Systematic Review. JAMA. Netw. Open 4, e2128568. doi:&#xa0;10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C., Bonifay A., Burtey S., Sabatier F., Cauchois R., Abdili E., et al. . (2021). Dissemination of Extreme Levels of Extracellular Vesicles: Tissue Factor Activity in Patients With Severe COVID-19. Blood Adv. 5, 628&#x2013;634. doi:&#xa0;10.1182/bloodadvances.2020003308</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003308</ArticleId><ArticleId IdType="pmc">PMC7846479</ArticleId><ArticleId IdType="pubmed">33560376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N., Zhao Y. Y., Evans C. E. (2019). The Stimulation of Thrombosis by Hypoxia. Thromb. Res. 181, 77&#x2013;83. doi:&#xa0;10.1016/j.thromres.2019.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2019.07.013</ArticleId><ArticleId IdType="pubmed">31376606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonmarker S., Hollenberg J., Dahlberg M., Stackelberg O., Litorell J., Everhov &#xc5;.H., et al. . (2020). Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients. Crit. Care 24, 653. doi:&#xa0;10.1186/s13054-020-03375-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03375-7</ArticleId><ArticleId IdType="pmc">PMC7680989</ArticleId><ArticleId IdType="pubmed">33225952</ArticleId></ArticleIdList></Reference><Reference><Citation>Karn V., Ahmed S., Tsai L. W., Dubey R., Ojha S., Singh H. N., et al. . (2021). Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 9. doi:&#xa0;10.3390/biomedicines9101373</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101373</ArticleId><ArticleId IdType="pmc">PMC8533559</ArticleId><ArticleId IdType="pubmed">34680490</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J. S., Caricchio R., Casanova J. L., Combes A. J., Diamond B., Fox S. E., et al. . (2021). The Intersection of COVID-19 and Autoimmunity. J. Clin. Invest. 131, e154886. doi:&#xa0;10.1172/JCI154886</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollias A., Poulakou G., Dimakakos E., Kyriakoulis K. G., Syrigos K. (2021). Thromboprophylaxis in COVID-19: Early Initiation Might Be as Important as Optimal Dosing. Thromb. Res. 204, 134&#x2013;135. doi:&#xa0;10.1016/j.thromres.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8206617</ArticleId><ArticleId IdType="pubmed">34144797</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E., Gavriatopoulou M., Fotiou D., Ntanasis-Stathopoulos I., Dimopoulos M. A., Terpos E. (2022). Late-Onset Hematological Complications Post COVID-19: An Emerging Medical Problem for the Hematologist. Am. J. Hematol. 97, 119&#x2013;128. doi:&#xa0;10.1002/ajh.26384</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26384</ArticleId><ArticleId IdType="pmc">PMC8646944</ArticleId><ArticleId IdType="pubmed">34687462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacout C., Rogez J., Orvain C., Nicot C., Rony L., Julien H., et al. . (2021). A New Diagnosis of Systemic Capillary Leak Syndrome in a Patient With COVID-19. Rheumatol. (Oxford). 60, e19&#x2013;e20. doi:&#xa0;10.1093/rheumatology/keaa606</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa606</ArticleId><ArticleId IdType="pmc">PMC7543632</ArticleId><ArticleId IdType="pubmed">32940700</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Coppens M. (2021). Vascular Mechanisms and Manifestations of COVID-19. Lancet Respir. Med. 9, 551&#x2013;553. doi:&#xa0;10.1016/S2213-2600(21)00221-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00221-6</ArticleId><ArticleId IdType="pmc">PMC8128673</ArticleId><ArticleId IdType="pubmed">34015324</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q., Li J., Hu X., Bai Y., Zheng Y., Gao Z. (2021). Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front. Med. (Lausanne). 8. doi:&#xa0;10.3389/fmed.2021.702635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P. A., Cuapio A., et al. . (2021). More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 11, 16144. doi:&#xa0;10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Madureira G., Soares R. (2021). The Misunderstood Link Between SARS-CoV-2 and Angiogenesis. A Narrative Review. Pulmonology S2531-0437 (21). doi:&#xa0;10.1016/j.pulmoe.2021.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.08.004</ArticleId><ArticleId IdType="pmc">PMC8390375</ArticleId><ArticleId IdType="pubmed">34593362</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., et al. . (2022). Post-Acute COVID-19 Syndrome (PCS) and Health-Related Quality of Life (Hrqol)-A Systematic Review and Meta-Analysis. J. Med. Virol. 94, 253&#x2013;262. doi:&#xa0;10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Matli K., Farah R., Maalouf M., Chamoun N., Costanian C., Ghanem G. (2021). Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review. Open Heart. 8, e001628. doi:&#xa0;10.1136/openhrt-2021-001628</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2021-001628</ArticleId><ArticleId IdType="pmc">PMC8186323</ArticleId><ArticleId IdType="pubmed">34099529</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish M. L., Goshua G., Liu Y., Fine R., Amin K., Chang E., et al. . (2021). Intermediate-Dose Anticoagulation, Aspirin, and in-Hospital Mortality in COVID-19: A Propensity Score-Matched Analysis. Am. J. Hematol. 96, 471&#x2013;479. doi:&#xa0;10.1002/ajh.26102</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26102</ArticleId><ArticleId IdType="pmc">PMC8013588</ArticleId><ArticleId IdType="pubmed">33476420</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., et al. . (2021). Characterising Long COVID: A Living Systematic Review. BMJ Glob. Health 6, e005427. doi:&#xa0;10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Moasefi N., Fouladi M., Norooznezhad A. H., Yarani R., Rahmani A., Mansouri K. (2021). How Could Perfluorocarbon Affect Cytokine Storm and Angiogenesis in Coronavirus Disease 2019 (COVID-19): Role of Hypoxia-Inducible Factor 1&#x3b1;. Inflamm. Res. 70, 749&#x2013;752. doi:&#xa0;10.1007/s00011-021-01469-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-021-01469-8</ArticleId><ArticleId IdType="pmc">PMC8233630</ArticleId><ArticleId IdType="pubmed">34173853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed-Hussein A. A. R., Aly K. M. E., Ibrahim M. A. A. (2020). Should Aspirin Be Used for Prophylaxis of COVID-19-Induced Coagulopathy? Med. Hypotheses. 144, 109975. doi:&#xa0;10.1016/j.mehy.2020.109975</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109975</ArticleId><ArticleId IdType="pmc">PMC7834233</ArticleId><ArticleId IdType="pubmed">32531536</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores L. K., Tritschler T., Brosnahan S., Carrier M., Collen J. F., Doerschug K., et al. . (2020). Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest 158, 1143&#x2013;1163. doi:&#xa0;10.1016/j.chest.2020.05.559</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.05.559</ArticleId><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N. N., Hoang V. T., Dao T. L., Dudouet P., Eldin C., Gautret P. (2022). Clinical Patterns of Somatic Symptoms in Patients Suffering From Post-Acute Long COVID: A Systematic Review. Eur. J. Clin. Microbiol. Infect. Dis. 41, 515&#x2013;545. doi:&#xa0;10.1007/s10096-022-04417-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-022-04417-4</ArticleId><ArticleId IdType="pmc">PMC8830952</ArticleId><ArticleId IdType="pubmed">35142947</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. (2021). SARS-Cov-2 Related Microvascular Damage and Symptoms During and After COVID-19: Consequences of Capillary Transit-Time Changes, Tissue Hypoxia and Inflammation. Physiol. Rep. 9, e14726. doi:&#xa0;10.14814/phy2.14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., Scarabelli T. M., Chen-Scarabelli C., Saravolatz L., et al. . (2021). Serum Metabolic Profile in Patients With Long-COVID (PASC) Syndrome: Clinical Implications. Front. Med. (Lausanne). 8. doi:&#xa0;10.3389/fmed.2021.714426</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R., Bogue T., Koshy A., Bindal P., Merrill M., Aird W. C., et al. . (2020). Postdischarge Thrombosis and Hemorrhage in Patients With COVID-19. Blood 136, 1342&#x2013;1346. doi:&#xa0;10.1182/blood.2020007938</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Lu S., Tang A., Durstenfeld M. S., Ho H. E., Goldberg S. A., et al. . (2021). Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 224, 1839&#x2013;1848. doi:&#xa0;10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J. A., Laubscher G. J., Steenkamp J., et al. . (2021). Persistent Clotting Protein Pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Is Accompanied by Increased Levels of Antiplasmin. Cardiovasc. Diabetol. 20, 172. doi:&#xa0;10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E., Agati L., Calderaro D., Aguiar V. C. R., Spyropoulos A. C., de Oliveira C. C. C., et al. . (2022). Rivaroxaban Versus No Anticoagulation for Post-Discharge Thromboprophylaxis After Hospitalisation for COVID-19 (MICHELLE): An Open-Label, Multicentre, Randomised, Controlled Trial. Lancet 399, 50&#x2013;59. doi:&#xa0;10.1016/S0140-6736(21)02392-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentsch C. T., Beckman J. A., Tomlinson L., Gellad W. F., Alcorn C., Kidwai-Khan F., et al. . (2021). Early Initiation of Prophylactic Anticoagulation for Prevention of Coronavirus Disease 2019 Mortality in Patients Admitted to Hospital in the United States: Cohort Study. BMJ 372, n311. doi:&#xa0;10.1136/bmj.n311</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n311</ArticleId><ArticleId IdType="pmc">PMC7876672</ArticleId><ArticleId IdType="pubmed">33574135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizk J. G., Lavie C. J., Gupta A. (2021). Low-Dose Aspirin for Early COVID-19: Does the Early Bird Catch the Worm? Expert. Opin. Investig. Drugs 30, 785&#x2013;788. doi:&#xa0;10.1080/13543784.2021.1950687</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2021.1950687</ArticleId><ArticleId IdType="pubmed">34190669</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez C., Luque N., Blanco I., Sebastian L., Barber&#xe0; J. A., Peinado V. I., et al. . (2021). Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients With COVID-19. Am. J. Respir. Cell Mol. Biol. 64, 407&#x2013;415. doi:&#xa0;10.1165/rcmb.2020-0359PS</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0359PS</ArticleId><ArticleId IdType="pmc">PMC8008805</ArticleId><ArticleId IdType="pubmed">33180562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolla R., Puricelli C., Bertoni A., Boggio E., Gigliotti C. L., Chiocchetti A., et al. . (2021). Platelets: &#x201c;Multiple Choice&#x201d; Effectors in the Immune Response and Their Implication in COVID-19 Thromboinflammatory Process. Int. J. Lab. Hematol. 43, 895&#x2013;906. doi:&#xa0;10.1111/ijlh.13516</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.13516</ArticleId><ArticleId IdType="pmc">PMC8251141</ArticleId><ArticleId IdType="pubmed">33749995</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosell A., Havervall S., von Meijenfeldt F., Hisada Y., Aguilera K., Grover S. P., et al. . (2021). Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arterioscler. Thromb. Vasc. Biol. 41, 878&#x2013;882. doi:&#xa0;10.1161/ATVBAHA.120.315547</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315547</ArticleId><ArticleId IdType="pmc">PMC7837685</ArticleId><ArticleId IdType="pubmed">33267656</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F., Nu&#xf1;ez-Gil I. J., Vitale E., Viana-Llamas M. C., Reche-Martinez B., Romero-Pareja R., et al. . (2022). Antiplatelet Therapy and Outcome in COVID-19: The Health Outcome Predictive Evaluation Registry. Heart 108, 130&#x2013;136. doi:&#xa0;10.1136/heartjnl-2021-319552</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-319552</ArticleId><ArticleId IdType="pmc">PMC8494537</ArticleId><ArticleId IdType="pubmed">34611045</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos A. C., Levy J. H., Ageno W., Connors J. M., Hunt B. J., Iba T., et al. . (2020). Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention, and Treatment of Venous Thromboembolism in Hospitalized Patients With COVID-19. J. Thromb. Haemost. 18, 1859&#x2013;1865. doi:&#xa0;10.1111/jth.14929</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14929</ArticleId><ArticleId IdType="pmc">PMC7283841</ArticleId><ArticleId IdType="pubmed">32459046</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K., Massberg S. (2021). Interplay Between Inflammation and Thrombosis in Cardiovascular Pathology. Nat. Rev. Cardiol. 18, 666&#x2013;682. doi:&#xa0;10.1038/s41569-021-00552-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Styp-Rekowska B., Hlushchuk R., Pries A. R., Djonov V. (2011). Intussusceptive Angiogenesis: Pillars Against the Blood Flow. Acta Physiol. (Oxf). 202, 213&#x2013;223. doi:&#xa0;10.1111/j.1748-1716.2011.02321.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.2011.02321.x</ArticleId><ArticleId IdType="pubmed">21535415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. . (2021). Attributes and Predictors of Long COVID. Nat. Med. 27, 626&#x2013;631. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taccone F. S., Gevenois P. A., Peluso L., Pletchette Z., Lheureux O., Brasseur A., et al. . (2020). Higher Intensity Thromboprophylaxis Regimens and Pulmonary Embolism in Critically Ill Coronavirus Disease 2019 Patients. Crit. Care Med. 48, e1087&#x2013;e1090. doi:&#xa0;10.1097/CCM.0000000000004548</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004548</ArticleId><ArticleId IdType="pmc">PMC7437413</ArticleId><ArticleId IdType="pubmed">32769623</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E., Ntanasis-Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T. N., Politou M., et al. . (2020). Hematological Findings and Complications of COVID-19. Am. J. Hematol. 95, 834&#x2013;847. doi:&#xa0;10.1002/ajh.25829</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J. (2021). Hypoxia-an Overlooked Trigger for Thrombosis in COVID-19 and Other Critically Ill Patients. J. Thromb. Haemost. 18, 3109&#x2013;3110. doi:&#xa0;10.1111/jth.15029</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15029</ArticleId><ArticleId IdType="pmc">PMC9770767</ArticleId><ArticleId IdType="pubmed">32726507</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanassche T., Orlando C., Vandenbosch K., Gadisseur A., Hermans C., Jochmans K., et al. . (2020). Belgian Clinical Guidance on Anticoagulation Management in Hospitalised and Ambulatory Patients With COVID-19. Acta Clin. Belg., 1&#x2013;6. doi:&#xa0;10.1080/17843286.2020.1829252</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17843286.2020.1829252</ArticleId><ArticleId IdType="pubmed">33012274</ArticleId></ArticleIdList></Reference><Reference><Citation>Viecca M., Radovanovic D., Forleo G. B., Santus P. (2020). Enhanced Platelet Inhibition Treatment Improves Hypoxemia in Patients With Severe COVID-19 and Hypercoagulability. A Case Control, Proof of Concept Study. Pharmacol. Res. 158, 104950. doi:&#xa0;10.1016/j.phrs.2020.104950</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104950</ArticleId><ArticleId IdType="pmc">PMC7244436</ArticleId><ArticleId IdType="pubmed">32450344</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt F. A., Havervall S., Adelmeijer J., Lundstr&#xf6;m A., Magnusson M., Mackman N., et al. . (2021). Sustained Prothrombotic Changes in COVID-19 Patients 4 Months After Hospital Discharge. Blood. Adv. 5, 756&#x2013;759. doi:&#xa0;10.1182/bloodadvances.2020003968</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahid L., Ortel T. L. (2021). Anticoagulant Therapy in Patients Hospitalized With COVID-19. JAMA Intern. Med. 181, 1621&#x2013;1622. doi:&#xa0;10.1001/jamainternmed.2021.6212</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6212</ArticleId><ArticleId IdType="pubmed">34617968</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y. Y., Zhou W. M., Wang Y. Q., Guo Q. R., Zhao F. X., Zhu Z. Y., et al. . (2021). The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge. Front. Mol. Biosci. 8, 699929. doi:&#xa0;10.3389/fmolb.2021.699929</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.699929</ArticleId><ArticleId IdType="pmc">PMC8345113</ArticleId><ArticleId IdType="pubmed">34368228</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahran A. M., El-Badawy O., Ali W. A., Mahran Z. G., Mahran E. E. M. O., Rayan A. (2021). Circulating Microparticles and Activated Platelets as Novel Prognostic Biomarkers in COVID-19; Relation to Cancer. PLoS. One 16, e0246806. doi:&#xa0;10.1371/journal.pone.0246806</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246806</ArticleId><ArticleId IdType="pmc">PMC7899358</ArticleId><ArticleId IdType="pubmed">33617530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., et al. . (2020). Platelets can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19. Circ. Res. 127, 1404&#x2013;1418. doi:&#xa0;10.1161/CIRCRESAHA.120.317703</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>